CancerWorld Special Issue

CancerWorld Special Issue

We’re excited to announce our collaboration with CancerWorld magazine! This special issue is about the 25th anniversary of an oral medication for chronic myeloid leukemia that transformed treatment, diagnostics, access, and patient advocacy.

It features articles from the global community, including clinicians, researchers, patients, and advocates. Learn more about how a woman living with CML started helping others navigate their diagnosis, or the successes and challenges that come with providing treatment in a low-income country. Each voice has something special to share.

Read More

See All News

The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.

Related Articles

  • The Max Foundation Establishes Unprecedented Network of Leading Cancer Providers in LMIC

    The Max Foundation Establishes Unprecedented Network of Leading Cancer Providers in LMIC

    In an effort to strengthen health outcomes for patients in low resource settings, The Max Foundation and its subsidiary, MaxAid, have signed Collaboration Agreements with 140 individual hematologists and oncologists from leading National Cancer Institutes and clinics in 60 low and middle income countries. With the formal establishment of this network, The Max Foundation completes its validated supply chain into each of the countries, providing a safe environment through which to channel humanitarian donations of cancer treatment with end-to-end controls.

  • The Max Foundation and Cepheid expand collaboration to increase access to diagnostics

    The Max Foundation and Cepheid expand collaboration to increase access to diagnostics

    The Max Foundation and Cepheid have renewed and expanded their collaboration to increase access to molecular diagnostics in low- and middle-income countries (LMICs).

  • The Max Foundation’s access program exceeds 10 million daily doses of cancer treatment distributed to patients worldwide

    The Max Foundation’s access program exceeds 10 million daily doses of cancer treatment distributed to patients worldwide

    Since the launch of Max Access Solutions in 2017, The Max Foundation has delivered over 10 million daily doses of cancer treatment to patients in more than 70 low- and middle-income countries.